Lornoxicam (Dosage)

Lornoxicam is a medication belonging to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is mainly used for the relief of pain and inflammation.

Lornoxicam is an NSAID analgesic belonging to the oxicam class, used for mild to moderate acute and chronic pain and also acts as an anti-inflammatory and antipyretic. It is indicated for musculoskeletal pain, postoperative pain, inflammation in rheumatoid arthritis, osteoarthritis, acute lumbar-sciatic conditions, dysmenorrhea, and soft tissue inflammation.

MECHANISM OF ACTION

Lornoxicam is a potent inhibitor of cyclooxygenase enzymes (COX-1 and COX-2), which acts by reducing the synthesis of prostaglandins, substances that mediate pain, inflammation, and fever.

CONTRAINDICATIONS

Lornoxicam treatment is contraindicated in the following cases:

  • Patients with hypersensitivity to NSAIDs, including acetylsalicylic acid.
  • Acute heart failure.
  • History of gastrointestinal perforation or bleeding related to the use of NSAIDs.
  • Presence of active or previous gastrointestinal ulcers or bleeding.
  • Cerebrovascular hemorrhages or other types of active bleeding.
  • During the third trimester of pregnancy.
  • Patients with acute renal or hepatic failure.

SIDE EFFECTS

The most frequent adverse reactions are mild headache, dizziness, nausea, abdominal pain, dyspepsia, diarrhea, vomiting.

INTERACTIONS

Lornoxicam can interact with multiple medications, so it is recommended to inform your doctor of all the medications you are taking. Lornoxicam interacts with NSAIDs (such as acetylsalicylic acid and ibuprofen) and anticoagulant agents (such as warfarin) and antiplatelet agents (e.g., clopidogrel) and may lead to an increased risk of bleeding. NSAIDs decrease the therapeutic effect of antihypertensive drugs and should be used with caution in patients with underlying hypertension. It also interacts with corticosteroids, cimetidine, immunosuppressants, lithium, selective serotonin reuptake inhibitors (SSRIs), sulfonylureas, and some antibiotics, among other medications.

BRAND NAMES

  • Acabel®
  • Bosporón®
  • Lormex®
  • Lornicam®
  • Lornoxicam Rapid meiji®
  • Taigalor®
  • Xefo®
  • Xefocam®

Genes analyzed

CYP2C9

Bibliography

Choi CI, Kim MJ, Jang CG, et al. Effects of the CYP2C9*1/*13 genotype on the pharmacokinetics of lornoxicam. Basic Clin Pharmacol Toxicol. 2011 Dec;109(6):476-80.

Theken KN, Lee CR, Gong L, et al. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. Clin Pharmacol Ther. 2020 Aug;108(2):191-200.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy